Philip Alexander Poole‐wilson

Philip Alexander Poole‐wilson's AcademicInfluence.com Rankings

Medical

#1014

World Rank

#1302

Historical Rank

Cardiology

#55

World Rank

#56

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Philip Alexander Poole‐wilson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Philip Alexander Poole‐wilson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. (2000) (4196)
Universal definition of myocardial infarction. (2015) (2234)
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II (2000) (1955)
The Seattle Heart Failure Model: Prediction of Survival in Heart Failure (2006) (1797)
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial (2003) (1756)
Ferric carboxymaltose in patients with heart failure and iron deficiency. (2009) (1586)
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). (2005) (1481)
Wasting as independent risk factor for mortality in chronic heart failure (1997) (1299)
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. (1999) (1141)
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. (2006) (1111)
Prevention of coronary heart disease in clinical practice (1994) (1063)
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care (1997) (937)
Endotoxin and immune activation in chronic heart failure: a prospective cohort study (1999) (812)
Exercise Intolerance in Adult Congenital Heart Disease: Comparative Severity, Correlates, and Prognostic Implication (2005) (736)
Stress (Takotsubo) cardiomyopathy—a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning (2008) (641)
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study (2003) (637)
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. (2005) (580)
Six minute walking test for assessing exercise capacity in chronic heart failure. (1986) (574)
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis (2005) (573)
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial (2009) (525)
Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. (1994) (519)
Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. (1987) (517)
Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. (2007) (508)
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial (2004) (508)
17β-Estradiol Attenuates Acetylcholine-Induced Coronary Arterial Constriction in Women but Not Men With Coronary Heart Disease (1995) (507)
Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. (1995) (505)
Altered intestinal function in patients with chronic heart failure. (2007) (491)
Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. (1993) (479)
Nitric oxide attenuates cardiac myocyte contraction. (1993) (455)
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). (2009) (449)
Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease (1993) (444)
Idiopathic dilated cardiomyopathy. (1990) (414)
The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. (2004) (413)
Testosterone relaxes rabbit coronary arteries and aorta. (1995) (412)
Enhanced Ventilatory Response to Exercise in Patients With Chronic Heart Failure and Preserved Exercise Tolerance: Marker of Abnormal Cardiorespiratory Reflex Control and Predictor of Poor Prognosis (2001) (408)
Hypoxia and calcium. (1979) (402)
Abnormalities of skeletal muscle in patients with chronic heart failure. (1988) (395)
Endothelium‐independent relaxation of rabbit coronary artery by 17β‐oestradiol in vitro (1991) (388)
Anabolic Deficiency in Men With Chronic Heart Failure: Prevalence and Detrimental Impact on Survival (2006) (378)
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial (2005) (375)
Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy (1998) (367)
Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. (1992) (361)
Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. (1989) (347)
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. (2000) (344)
Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. (1993) (305)
Prediction of Mode of Death in Heart Failure: The Seattle Heart Failure Model (2007) (291)
Age-Dependent Impairment of Endothelial Progenitor Cells Is Corrected by Growth Hormone Mediated Increase of Insulin-Like Growth Factor-1 (2007) (290)
Cardiovascular protection by oestrogen—a calcium antagonist effect? (1993) (281)
Abnormal Ventilatory Response to Exercise in Adults With Congenital Heart Disease Relates to Cyanosis and Predicts Survival (2006) (275)
Prevalence, Predictors, and Prognostic Value of Renal Dysfunction in Adults With Congenital Heart Disease (2008) (268)
Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. (2011) (265)
The time of onset and severity of acidosis in myocardial ischaemia. (1980) (251)
Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. (2005) (245)
Pathogenesis of Congestive State in Chronic Obstructive Pulmonary Disease: Studies of Body Water and Sodium, Renal Function, Hemodynamics, and Plasma Hormones During Edema and After Recovery (1992) (242)
Effect of 17β‐oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea‐pig isolated cardiac myocytes (1992) (237)
Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure. (1990) (236)
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. (2002) (234)
Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. (2007) (233)
Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. (1998) (227)
The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. (2006) (227)
Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population (2009) (224)
Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. (2002) (218)
Calcium out of control. (1984) (215)
Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’ [Eur Heart J 2008;29:2388–2442 and Eur J Heart Fail 2008;10:933–989] (2009) (208)
Heart rate response during exercise predicts survival in adults with congenital heart disease. (2006) (206)
The Effects of Verapamil, Quiescence, and Cardioplegia on Calcium Exchange and Mechanical Function in Ischemic Rabbit Myocardium (1982) (206)
Acute effect of 17 beta-estradiol on rabbit coronary artery contractile responses to endothelin-1. (1992) (206)
Symptoms in patients with heart failure are prognostic predictors: insights from COMET. (2005) (198)
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. (2005) (191)
The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic resonance study. (2004) (191)
The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. (2005) (186)
Prevalence and outcome of subclinical rheumatic heart disease in India: The RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study (2011) (171)
Direct measurement of skeletal muscle fatigue in patients with chronic heart failure. (1991) (166)
SERCA2a Gene Transfer Decreases Sarcoplasmic Reticulum Calcium Leak and Reduces Ventricular Arrhythmias in a Model of Chronic Heart Failure (2011) (165)
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey (2005) (163)
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial. (2000) (160)
Factors determining symptoms in heart failure: comparison of fast and slow exercise tests. (1986) (160)
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol european trial (COMET): randomized controlled trial☆ (2003) (158)
Mode of death in heart failure: findings from the ATLAS trial (2003) (156)
Effects of ischaemia and reperfusion on calcium exchange and mechanical function in isolated rabbit myocardium. (1981) (152)
17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X. (1996) (150)
Effect of anemia on exercise tolerance in chronic heart failure in men. (2003) (150)
Effect of pH on ionic exchange and function in rat and rabbit myocardium. (1975) (150)
Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist. (1996) (149)
Respiratory gas exchange in the assessment of patients with impaired ventricular function. (1985) (147)
Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial (2004) (146)
Is aspirin safe for patients with heart failure? (1995) (145)
Successes and failures of current treatment of heart failure (1998) (142)
Publication Committee for the VMAC Investigators Randomized Controlled Trial Decompensated Congestive Heart Failure: A Intravenous Nesiritide vs Nitroglycerin for Treatment of (2009) (140)
Effects of acid‐base changes on excitation‐‐contraction coupling in guinea‐pig and rabbit cardiac ventricular muscle. (1981) (136)
First permanent implant of the Jarvik 2000 Heart (2000) (134)
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial (2005) (132)
Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. (2003) (132)
Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro. (1992) (132)
Autonomic imbalance and immune activation in chronic heart failure - pathophysiological links. (2006) (126)
Is altered cardiac sensation responsible for chest pain in patients with normal coronary arteries? Clinical observation during cardiac catheterisation (1988) (126)
Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients (2005) (125)
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials (2009) (123)
17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. (1995) (120)
Role of Cardiovascular Magnetic Resonance as a Gatekeeper to Invasive Coronary Angiography in Patients Presenting With Heart Failure of Unknown Etiology (2011) (119)
Syndrome X in women is associated with oestrogen deficiency. (1995) (118)
Predictors of clinical outcomes in elderly patients with heart failure (2011) (116)
Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia (2009) (114)
Reactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel. (1991) (112)
Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy. (2006) (112)
Adaptive servo-ventilation in heart failure patients with sleep apnea: a real world study. (2010) (108)
A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy. (2007) (105)
Should beta‐blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET (2007) (104)
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients. (2006) (103)
Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin. (1985) (102)
Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial (2009) (96)
Abnormal autonomic control of the cardiovascular system in syndrome X. (1994) (95)
Continuous recording of coronary sinus oxygen saturation during atrial pacing in patients with coronary artery disease or with syndrome X. (1988) (95)
Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. (2004) (95)
Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II. (1999) (94)
Circulating estradiol and mortality in men with systolic chronic heart failure. (2009) (93)
Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET (2002) (93)
Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. (2008) (92)
Haemoglobin concentration and prognosis in new cases of heart failure (2003) (91)
Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. (1994) (91)
A protective effect of a mild acidosis on hypoxic heart muscle. (1977) (86)
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial. (2007) (85)
Intracellular pH and K+ of cardiac and skeletal muscle in acidosis and alkalosis. (1975) (84)
Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial. (2006) (84)
Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. (2009) (82)
Prognostic importance of plasma NT‐pro BNP in chronic heart failure in patients treated with a β‐blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial (2007) (81)
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival. (2001) (79)
Angina and normal coronary arteries in women: gynecologic findings. (1992) (79)
Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET. (2005) (78)
Abnormal diastolic filling patterns in chronic heart failure--relationship to exercise capacity. (1992) (77)
Incidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom (2005) (76)
ECS, intracellular pH, and electrolytes of cardiac and skeletal muscle. (1975) (75)
Cellular mechanisms of contractile dysfunction in human heart failure. (1996) (75)
Treatment of chronic heart failure: a review of recent drug trials. (1985) (74)
A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET). (2006) (74)
Pulmonary artery pressure and activities in chronic heart failure (1990) (74)
Diuretics for heart failure. (2012) (73)
Effects of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal blood flow and hormone levels in congestive heart failure. (1991) (73)
Cardiothoracic ratio from postero-anterior chest radiographs: a simple, reproducible and independent marker of disease severity and outcome in adults with congenital heart disease. (2013) (73)
The effect of β-adrenoceptor and Ca2+ antagonist drugs on the hypoxia-induced increase in resting tension (1978) (72)
Mechanisms of β adrenoceptor desensitisation in the failing human heart (1994) (72)
Symptoms limiting exercise in chronic heart failure. (1986) (71)
Circulatory Support for Long-Term Treatment of Heart Failure: Experience With an Intraventricular Continuous Flow Pump (2002) (71)
Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. (1990) (71)
Measurement of cardiac output during exercise by the thermodilution and direct Fick techniques in patients with chronic congestive heart failure. (1985) (69)
Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure. (2008) (68)
Interventional vs. conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the british heart foundation RITA 3 randomized trial☆ (2003) (68)
Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design. (2002) (65)
Effects of acidosis on mechanical function and Ca2+ exchange in rabbit myocardium. (1979) (64)
Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism. (1996) (64)
Cardiac arrhythmogenesis and the gap junction. (1995) (64)
Myocarditis--continuing clinical and pathologic confusion. (1991) (63)
Relation of pathophysiologic mechanisms to outcome in heart failure. (1993) (62)
Pathogenesis of Edema in Constrictive Pericarditis: Studies of Body Water and Sodium, Renal Function, Hemodynamics, and Plasma Hormones Before and After Pericardiectomy (1991) (61)
Effect of 17 beta-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. (1992) (61)
Regenerative capacity of the myocardium: implications for treatment of heart failure (2004) (61)
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial. (2012) (60)
The safety of amiodarone in patients with heart failure. (2007) (59)
Salbutamol in treatment of heart failure. (1980) (59)
Distribution of knowledge. (1997) (59)
Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. (2001) (58)
R wave amplitude during exercise. Relation to left ventricular function and coronary artery disease. (1980) (58)
Diurnal variation of pulmonary artery pressure in chronic heart failure. (1989) (57)
Calcium exchange in rabbit myocardium during and after hypoxia: effect of temperature and substrate. (1980) (57)
Hyponatraemia: A strong predictor of mortality in adults with congenital heart disease. (2010) (57)
Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET. (2007) (56)
Measurement of myocardial intracellular pH in pathological states. (1978) (56)
Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia (1990) (56)
Isoproterenol sensitivity of isolated cardiac myocytes from rats with monocrotaline-induced right-sided hypertrophy and heart failure. (1989) (55)
Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants (2009) (54)
Beta-Blockers in Heart Failure: Are Pharmacological Differences Clinically Important? (2004) (54)
Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins (2005) (52)
Effects of Thiopental on Tension Development, Action Potential, and Exchange of Calcium and Potassium in Rabbit Ventricular Myocardium (1981) (52)
Heart failure : scientific principles and clinical practice (1997) (51)
Cardiac myocyte apoptosis. (1999) (49)
Coronary flow reserve in patients with chest pain and normal coronary arteries. (1993) (48)
Logical approach to lignocaine therapy. (1976) (48)
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue. (2004) (48)
QT Dispersion Has No Prognostic Value in Patients with Symptomatic Heart Failure: An ELITE II Substudy (2003) (48)
A comparison of the ventilatory response to carbon dioxide by steady-state and rebreathing methods during metabolic acidosis and alkalosis. (1973) (47)
Coronary sinus potassium concentration recorded during coronary angioplasty. (1983) (47)
Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial (2017) (47)
Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death. (1992) (47)
Impairment of endothelium dependent responses in a rat model of chronic heart failure: effects of an exercise training protocol. (1992) (47)
ACE inhibitors for heart failure: a question of dose. (1994) (46)
Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System. (1998) (46)
Tissue acidosis in myocardial hypoxia. (1980) (46)
The underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure. (2001) (44)
Treatment of heart failure with diuretics: body compartments, renal function and plasma hormones. (1989) (44)
Effect of carvedilol and metoprolol on the mode of death in patients with heart failure (2007) (44)
Role of skeletal muscle in the syndrome of chronic heart failure. (1996) (43)
Angina with normal coronary arteries: a review. (1989) (43)
The 6-minute walk. A simple test with clinical application. (2000) (42)
Lower patients' cholesterol now (1995) (42)
Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II). (2005) (42)
Variation in severity and type of sleep-disordered breathing throughout 4 nights in patients with heart failure. (2008) (41)
Potassium and the heart. (1984) (41)
Causes of symptoms in chronic congestive heart failure and implications for treatment. (1988) (40)
Modeling payback from research into the efficacy of left-ventricular assist devices as destination therapy (2007) (40)
Endothelial control of lower limb blood flow in chronic heart failure. (1996) (40)
Contamination of a cardiac sarcolemmal preparation with endothelial plasma membrane. (1986) (40)
Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial Investigators. (1998) (40)
WITHDRAWN: Diuretics for heart failure. (2016) (39)
International Society and Federation of Cardiology: Working Group on Classification of Calcium Antagonists for Cardiovascular Disease. (1987) (39)
Tissue expression of endothelin-1 mRNA in endotoxaemia. (1996) (39)
Beneficial effect of estrogen on exercise‐induced myocardial ischemia in women with coronary artery disease (1994) (39)
The cardiac component of cardiac cachexia. (2002) (38)
Cellular mechanisms of cardiac hypertrophy. (1995) (38)
Authors' response to “Stress (Takotsubo) cardiomyopathy—a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning” (2008) (37)
Impaired baroreflex sensitivity and sympathovagal balance in syndrome X. (1998) (37)
Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure (2009) (37)
Calcium antagonists: definition and mode of action (2005) (36)
Exchange of β‐blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial) (2004) (36)
Adriamycin cardiomyopathy in the rabbit: alterations in contractile proteins and myocyte function. (1990) (36)
Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy. (1996) (36)
Continuous coronary sinus and arterial pH monitoring during pacing-induced ischaemia in coronary artery disease. (1982) (36)
Potassium loss from rabbit myocardium during hypoxia: evidence for passive efflux linked to anion extrusion. (1986) (35)
Acidosis and contractility of heart muscle. (2008) (34)
[Prevention of coronary disease in clinical practice. Recommendations of the Task-Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension]. (1995) (34)
Treatment of acute heart failure: out with the old, in with the new. (2002) (33)
Incidence and outcome of atrial fibrillation in stable symptomatic coronary disease (2006) (33)
Cellular endotoxin desensitization in patients with severe chronic heart failure (2005) (33)
IS EARLY DECLINE OF CARDIAC FUNCTION IN ISCHÆMIA DUE TO CARBON-DIOXIDE RETENTION? (1975) (33)
Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure. (1990) (33)
Transient autonomic dysfunction precedes ST-segment depression in patients with syndrome X. (1996) (32)
Effects of a new nonionic and a conventional ionic contrast agent on coronary sinus ionized calcium and left ventricular hemodynamics in dogs. (1985) (32)
Calcium overload and mechanical function in posthypoxic myocardium: biphasic effect of pH during hypoxia. (1979) (32)
Extrapolated maximal oxygen consumption: a new method for the objective analysis of respiratory gas exchange during exercise. (1988) (32)
Insulin resistance syndrome in postmenopausal women with cardiological syndrome X. (1995) (32)
Cardiovascular and hormonal effects of calcitonin gene-related peptide in congestive heart failure. (1991) (32)
Mechanisms of beta adrenoceptor desensitisation in the failing human heart. (1994) (31)
Potassium exchange in the human heart during atrial pacing and myocardial ischaemia. (1986) (31)
Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: effects of isosorbide dinitrate, dobutamine and captopril. (1987) (31)
Evidence that calcium influx on reoxygenation is not due to cell membrane disruption in the isolated rabbit heart. (1986) (31)
Resolution of central sleep apnoea following implantation of a left ventricular assist device. (2010) (31)
Beta-adrenoceptor subtype dependence of chronotropy in mouse embryonic stem cell-derived cardiomyocytes (2004) (30)
Anemia in adults with congenital heart disease relates to adverse outcome. (2009) (30)
Regional blood flow, muscle strength and skeletal muscle histology in severe congestive heart failure. (1988) (29)
An inhibitor of nitric oxide synthase does not increase contraction or beta-adrenoceptor sensitivity of ventricular myocytes from failing human heart. (1998) (29)
Syndrome X: an hypothesis for cardiac pain without ischaemia. (1991) (29)
Plasma CGRP-like immunoreactivity in treated and untreated congestive heart failure (1991) (29)
Heart failure: why and how to define it? (1999) (29)
SERCA 2 a Gene Transfer Decreases Sarcoplasmic Reticulum Calcium Leak and Reduces Ventricular Arrhythmias in a Model of Chronic Heart Failure (2011) (29)
Safety of Nifedipine GITS in Stable Angina: The ACTION Trial (2006) (28)
An experimental model of chronic cardiac failure using adriamycin in the rabbit: central haemodynamics and regional blood flow. (1987) (28)
Sodium exchange during hypoxia and on reoxygenation in the isolated rabbit heart. (1988) (28)
Circulatory failure in septic shock. Nitric oxide: too much of a good thing? (1993) (28)
Can heart rate variation rule out sleep-disordered breathing in heart failure? (2006) (28)
Definitive clinical assessment of atrial septal defect by magnetic resonance imaging. (1999) (27)
Heart failure in a district general hospital: are target doses of beta-blockers realistic? (2004) (27)
Regulation of intracellular pH in the myocardium; relevance to pathology (1989) (27)
Relations between resting ventricular long axis function, the electrocardiogram, and myocardial perfusion imaging in syndrome X. (1994) (27)
The prevention of cardiovascular disease worldwide: whose task and WHO's task? (2005) (26)
Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction. (2013) (26)
Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise. (1986) (26)
Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol. (1983) (26)
Effect of lemakalim on action potentials, intracellular calcium, and contraction in guinea pig and human cardiac myocytes. (1994) (25)
Cardiovascular specialty societies and the emerging global burden of cardiovascular disease: a call to action. (1998) (25)
Assessment of functional capacity in chronic heart failure: time-limited exercise on a self-powered treadmill. (1994) (25)
Chronic heart failure patients with restrictive LV filling pattern have significantly less benefit from cardiac resynchronization therapy than patients with late LV filling pattern. (2005) (25)
Trends and contexts in European cardiology practice for the next 15 years: the Madrid Declaration: a report from the European Conference on the Future of Cardiology, Madrid, 2-3 June 2006. (2006) (25)
Abnormal uptake and washout of thallium-201 in patients with syndrome X and normal-appearing scans. (1995) (25)
Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptors. (2005) (24)
The effects of intracoronary substance P and acetylcholine on coronary blood flow in patients with idiopathic dilated cardiomyopathy. (1994) (24)
Suppression of erythropoiesis in patients with chronic heart failure and anaemia of unknown origin: evidence of an immune basis. (2013) (24)
Catheter tip pH electrodes for continuous intravascular recording. (1980) (23)
Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure (2012) (23)
Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome (2007) (23)
Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses. (1981) (23)
Clinical course of isolated stable angina due to coronary heart disease. (2007) (22)
Enalapril as initial and sole treatment in severe chronic heart failure with sodium retention. (1990) (22)
Cardiac failure. (1998) (22)
ESC-CHF: guidelines for the aspirational and the practical (2005) (22)
Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’ [Eur Heart J 2008;29:2388–2442 and Eur J Heart Fail 2008;10:933–989] (2008) (22)
Diagnostic criteria and adjudication process both determine published event-rates: the ACTION trial experience. (2007) (21)
Central and peripheral quadriceps fatigue in congestive heart failure☆ (2013) (21)
Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate. (1983) (21)
The Cardiac Insufficiency Bisoprolol Study II (1999) (21)
Influence of R wave analysis upon diagnostic accuracy of exercise testing in women. (1982) (20)
Salbutamol in cardiogenic shock complicating acute myocardial infarction. (1980) (20)
High- versus low-dose angiotensin converting enzyme inhibitor therapy in the treatment of heart failure: an economic analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial. (2003) (20)
Endothelin-1 in heart failure: a new therapeutic target? (1996) (19)
Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial (2006) (19)
Acquired von Willebrand's Syndrome and Systemic Lupus Erythematosus (1972) (19)
Phenformin and metabolic acidosis. (1972) (19)
Ventricular extrasystoles during thiazide treatment. (1983) (19)
The enigma of syndrome X. (1989) (19)
Potassium efflux from the myocardium during hypoxia: role of lactate ions. (1987) (19)
Alpha-adrenoceptor stimulation, lysophosphoglycerides, and lipid peroxidation in reoxygenation induced calcium uptake in rabbit myocardium. (1985) (18)
Impairment of autonomic reactivity is a feature of heart failure whether or not the left ventricular ejection fraction is normal. (2011) (18)
5-Year Outcome of an Interventional Strategy in Non-ST-Elevation Acute Coronary Syndrome: The British Heart Foundation RITA-3 Randomized Trial (2005) (18)
Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study (1999) (17)
Diuretics as initial and sole treatment in chronic cardiac failure. (1991) (17)
Reperfusion damage in heart muscle: still unexplained but with new clinical relevance. (1987) (17)
Myocarditis — A Controversial Disease (1991) (17)
High potassium concentration in a parenteral preparation of glyceryl trinitrate. Need for caution if given by intracoronary injection. (1983) (17)
The ability of a submaximal exercise test to predict maximal exercise capacity in patients with heart failure. (1985) (17)
The calcium paradox in isolated frog heart: Ringer revisited. (1983) (17)
Neuroendocrine response to standing and mild exercise in patients with untreated severe congestive heart failure and chronic constrictive pericarditis. (1996) (17)
Hemodynamic, hormonal, and renal effects of atrial natriuretic peptide in untreated congestive cardiac failure. (1989) (17)
Global differences in the outcome of heart failure: implications for clinical practice. (2008) (16)
Prediction of Survival in Heart Failure (2006) (16)
ACE inhibitors and ARBs in chronic heart failure: the established, the expected, and the pragmatic. (2003) (16)
World Heart Day: a World Heart Federation enterprise promoting the prevention of heart disease and stroke across the world. (2003) (16)
Calcium exchange in rabbit myocardium during and after hypoxia: role of sodium-calcium exchange. (1990) (16)
Responses of the rabbit epicardial coronary artery to acetylcholine and adrenoceptor agonists. (1991) (15)
Angiosarcoma of pericardium. Problems in diagnosis and management. (1976) (15)
The therapeutic potential of new insights into myocardial excitation–contraction coupling (2003) (15)
Are calcium antagonists safe? (1995) (15)
Comparison of ventricular long-axis function in patients with cardiac amyloidosis versus idiopathic restrictive cardiomyopathy. (2005) (15)
Cardiac Flow Measurement by Ultrafast CT: Validation of Continuous and Pulsatile Flow (1992) (15)
A comparison of contractile function between papillary muscles and isolated myocytes from the same human hearts. (1991) (14)
Glycoside Inotropy in the Absence of an Increase in Potassium Efflux in the Rabbit Heart (1975) (14)
Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: The ACTION study. (2007) (14)
Inhibition by barium and glibenclamide of the net loss of 86Rb+ from rabbit myocardium during hypoxia. (1991) (14)
Maximal 12-lead exercise testing for prediction of severity of coronary artery disease. (1980) (14)
The calcium antagonist controversy; implications beyond drug prescription. (1996) (14)
Incomplete reversal of β‐adrenoceptor desensitization in human and guinea‐pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors (1993) (14)
Association of deranged adrenal steroid metabolism with anemia in chronic heart failure. (2005) (14)
The dimensions of human cardiac myocytes; confusion caused by methodology and pathology. (1995) (14)
Effect of nicardipine on left ventricular function and on angina induced by atrial pacing in patients with coronary artery disease. (1985) (14)
Acceleration of contraction by β-adrenoceptor stimulation is greater in ventricular myocytes from failing than non-failing human hearts (2004) (14)
Optimism derived from 7.5 years of continuous-flow circulatory support. (2010) (13)
Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure. (1981) (13)
C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure. (2009) (13)
Effect of ouabain in therapeutic concentrations on K+ exchange and contraction of human and rabbit myocardium. (1979) (13)
A new exercise test for the assessment of heart failure: use of a self powered treadmill. (1989) (13)
The role of digitalis in the future. (1984) (13)
Comparison of captopril and ibopamine in mild to moderate heart failure. (1997) (13)
Mechanism of cardiac output gain from cardiac resynchronization therapy in patients with coronary artery disease or idiopathic dilated cardiomyopathy. (2006) (12)
Images in cardiovascular medicine. Use of magnetic resonance imaging to demonstrate a fistula from the aorta to the right atrium. (1998) (12)
Coronary sinus pH during percutaneous transluminal coronary angioplasty: early development of acidosis during myocardial ischaemia in man. (1987) (12)
Unpredictable zero drift in intravascular micromanometer tipped catheters during long term pulmonary artery pressure recording: implications for catheter design. (1989) (12)
Myocardial potassium loss after acute coronary occlusion in humans. (1987) (12)
Optical transmission of normal and atheromatous arterial wall: a spectral analysis. (1986) (12)
Future perspectives in the management of congestive heart failure. (1990) (12)
CONTINUOUS MEASUREMENT OF pH IN CENTRAL ARTERIES AND VEINS (1979) (12)
Digoxin—A redundant drug in congestive cardiac failure (2004) (12)
Prediction of heart failure - an art aided by technology. (1997) (12)
Contractile function and response to agonists in myocytes from failing human heart. (1994) (12)
Comparison of rabbit coronary arterial relaxation induced by acetylcholine and lemakalim: activation of ATP sensitive potassium channels. (1991) (11)
A possible molecular mechanism for 'stunning' of the myocardium. (1991) (11)
A Description of the Clinical Characteristics at Baseline of Patients Recruited into the Carvedilol or Metoprolol European Trial (COMET) (2004) (11)
Treatment of angina pectoris: associations with symptom severity. (2005) (11)
New therapies for the management of acute heart failure (2003) (11)
Acute effects of diuretics on potassium exchange, mechanical function and the action potential in rabbit myocardium. (1978) (11)
Is aspirin safe in heart failure? More data (1996) (11)
Advances in the treatment of chronic heart failure. (1992) (11)
Timolol Maleate (MK 950) in the Treatment of Essential Hypertension (1973) (11)
Gender differences in cardiac remodeling and clinical outcomes in chronic stable angina pectoris (from the ACTION Trial). (2010) (11)
Mechanical circulatory support in the UK (2007) (11)
Quality management of a large randomized double-blind multi-centre trial: the ACTION experience. (2008) (11)
The Effects of Acidosis on Myocardial Function and the Uptake of Calcium during and after Hypoxia (1977) (10)
Diastolic coronary resistance after ischaemia in the isolated rabbit heart: effect of nifedipine. (1986) (10)
Effects of age and hyperlipidemia on rabbit coronary responses to neuropeptide Y and the interaction with norepinephrine (1993) (10)
Years‐needed‐to‐treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials (2009) (10)
Blood flow and skeletal muscle in patients with heart failure. (1992) (10)
Digoxin withdrawal in patients with heart failure. (1994) (10)
Anaemia of chronic disease in chronic heart failure: the emerging evidence. (2005) (10)
Estradiol-17β Attenuates Acetylcholine-Induced Cor-onary Arterial Constriction in Women but not Men with Coronary Heart Disease: S-5. (1995) (10)
Cardiac amyloidosis diagnosed incidentally by bone scintigraphy (2007) (10)
Commentary on the Carvedilol or Metoprolol European Trial (COMET). (2004) (10)
THROMBOSIS IN MYOCARDIAL INFARCTION (1985) (10)
The ST segment--the herald of ischaemia, the siren of misdiagnosis, or syndrome X? (1992) (10)
Tracking Coronary Calcification and Atherosclerotic Lesions in Patients with Stable Angina Pectoris Undergoing Nifedipine Therapy (2006) (10)
Exercise as a means of assessing heart failure and its response to treatment. (1989) (9)
Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudy. (2010) (9)
Diuretics, hypokalaemia and arrhythmias in hypertensive patients: still an unresolved problem. (1987) (9)
The NETWORK study. The effect of dose of an ACE-inhibitor on outcome in patients with heart failure (1996) (9)
Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventions. (2007) (9)
Eff ects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure ( HEAAL study ) : a randomised , double-blind trial (2009) (9)
Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure. (1987) (9)
Acute and follow-up studies with pirbuterol in heart failure (1981) (9)
R-wave amplitude and left ventricular volume: changes with nitroglycerine and atrial pacing. (1981) (8)
The effect of beta-adrenoceptor and Ca2+ antagonist drugs on the hypoxia-induced increased in resting tension. (1978) (8)
Current therapeutic principles in the acute management of severe congestive heart failure. (1988) (8)
Hypokalaemia induced by thiazide diuretics in the treatment of hypertension: a cause for concern, not nihilism. (1983) (8)
Measurement of pulmonary venous and arterial pH oscillations in dogs using catheter tip pH electrodes. (1983) (8)
Haemodynamic and regional blood flow changes after acute pulmonary microembolism in conscious rabbits. (1988) (8)
Hypothesis: Inhibition of endothelium‐derived relaxing factor by haemoglobin in the pathogenesis of pre‐eclampsia (1991) (8)
A comparison of hemodynamic effects of one-month oral captopril and enoximone treatment for severe congestive heart failure. (1987) (8)
The renal response to neuroendocrine inhibition in chronic heart failure: double-blind comparison of captopril and prazosin. (1986) (7)
Digitalis: dead or alive? (1988) (7)
ESSENTIAL – The Studies of Oral Enoximone Therapy in Advanced Heart Failure (2005) (7)
Differences in European and North American approaches to the management of heart failure. (2008) (7)
Tailored treatment for heart failure: An emerging concept. (1999) (7)
Obstacles to the initiation of β blockers for heart failure in a specialised clinic within a district general hospital (2003) (7)
Edema of Cardiac Origin (2005) (7)
Managing heart failure in primary care (1996) (7)
Angiotensin-Converting Enzyme Inhibitors or Vasodilators as Therapy in Chronic Heart Failure: A Review of the Trials (1992) (6)
Losartan for cardiovascular disease in patients with and without diabetes in the LIFE study (2002) (6)
NICE: guessing is not guidance (2002) (6)
[Trends and contexts in European cardiology practice for the next 15 years. The Madrid Declaration: a report from the European Conference on the Future of Cardiology, Madrid, 2-3 June 2006]. (2007) (6)
Amlodipine in chronic heart failure. (1997) (6)
Similarities and Differences in Design Considerations for Cell Therapy and Pharmacologic Cardiovascular Clinical Trials (2007) (6)
Doppler flow, echocardiography and functional improvement: assessment of nisoldipine therapy (defiant-II study): objectives and design (1993) (5)
Anemia and inflammation in chronic heart failure (2003) (5)
Angiotensin-converting enzyme inhibitors and calcium antagonists after acute myocardial infarction. (1995) (5)
Paradoxical embolism complicating massive pulmonary embolus. (1976) (5)
A comparison of the control of intracellular pH in cardiac and skeletal muscle. (1973) (5)
[Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)]. (1995) (5)
Perforation thresholds and safety factors in in vivo coronary laser angioplasty. (1988) (5)
Global cardiovascular disease prevention (2001) (5)
Subcellular mechanism of the species difference in the contractile response of ventricular myocytes to endothelin-1. (1993) (5)
Maximal oxygen uptake in severe aortic regurgitation: a different view of left ventricular function. (1990) (5)
Action: a 30,000 patient-years double-blind, placebo-controlled trial of nifedipine GITS in stable angina. ACTION Research Group. (1997) (5)
Implications of recent heart failure trials for patients with hypertension (2001) (5)
Responses of Coronary Arteries to Neurotransmitters: Changes with Sexual Maturity in the Female Rabbit (1991) (5)
Chronic heart failure. (2007) (5)
Focus on mechanical assist devices for the treatment of heart failure (2008) (5)
Influence of contractile state on the size of the extracellular space in isolated ventricular myocardium (1979) (5)
Genetic Epidemiology of Coronary Heart Disease: Past, Present and Future: Progress in Clinical and Biological Research, vol 147 (1985) (5)
Heart failure. Unfinished business--a possible role for vasodilators. (1993) (5)
Sixminute walking test forassessing exercise capacity in chronic heart failure (1986) (5)
Absence of a relationship between extracellular potassium accumulation and contractile failure in the ischemic or hypoxic rabbit heart. (1983) (5)
DMO method for intracellular pH. (1976) (5)
Respiratory gasexchange intheassessment ofpatients withimpaired ventricular function (1985) (5)
Coexistence of Functioning f- and 32-Adrenoceptors in Single Myocytes From Human Ventricle (2005) (4)
Global Differences in Atherosclerosis (2007) (4)
Ischaemia and reperfusion — Ions, channels and receptors (1990) (4)
Magnesium inhibits the responses to neuropeptide Y in the rabbit coronary artery. (1991) (4)
Limiting Symptoms in Chronic Heart Failure Are Dependent on Rate of Increase of Work Load and Independent of Haemodynamics (1984) (4)
Acute and Chronic Heart Failure: Positive Inotropes, Vasodilators, and Digoxin (2009) (4)
Glibenclamide and Barium Inhibit Endothelium-Dependent Relaxation Induced by Acetylcholine in Isolated Rabbit Coronary Arteries (1991) (4)
Treatment of angina: a commentary on new therapeutic approaches (2006) (4)
Diastolic coronary resistance in the isolated rabbit heart during and after ischaemia: contribution of extravascular forces. (1986) (4)
Clinical profile and outcome of anaemic patients with chronic heart failure in the COMET trial (2004) (4)
The influence of right heart catheterisation on pulmonary arterial pressure in chronic heart failure: relationship to neuroendocrinal changes. (1991) (4)
Continuous coronary sinus pH monitoring during dipyridamole stress in patients with angina and hypertrophic cardiomyopathy (1996) (4)
835-3 Beta-blocker dose does not influence the beneficial effects of carvedilol compared to metroprolol in the patients with heart failure: Results from the carvedilol or Metoprolol European Trial (COMET) (2004) (4)
95067866 Testosterone relaxes rabbit coronary arteries and aorta (1995) (4)
Digoxin in chronic heart failure. (1989) (4)
Therapeutic implications of diastolic dysfunction in heart failure. (1990) (4)
Cardiac myocytes and the cardiac action potential (2010) (4)
Cardiovascular health in Europe: a global problem. (2007) (4)
Spirals, paradigms, and the progression of heart failure. (1996) (4)
Resource utilization implications of treatment were able to be assessed from appropriately reported clinical trial data. (2007) (3)
Monday, 27 August 2012 (2012) (3)
Future strategies of reverse remodeling: summation. (2002) (3)
The reuse of medical devices : an ethical dilemma in a changing world (1999) (3)
Prevalence of Anaemia and the Effects of Nebivolol on Haemoglobin Values in Patients with Chronic Heart Failure: Results from the SENIORS Database (2009) (3)
835-4 Comparison of the effects of metoprolol and carvedilol on symptoms, well-being, and quality-adjusted life-years: A description of the patient-journey in COMET (2004) (3)
Coronary heart disease. (1992) (3)
Six Minute Walking Test for Assessing Exercise Capacity in Patients with Chronic Heart Failure (1986) (3)
The development of heart failure in patients with stable angina pectoris (2007) (3)
ELITE II (evaluation of losartan in the elderly) (2000) (3)
Pathophysiology of Heart Failure (2013) (3)
Rheumatic fever: the potential advantages of technology (2008) (3)
Evidence That Myocardial Potassium Loss during Ischaemia in Man Precedes Electrocardiographic Changes and Chest Pain (1983) (3)
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure : data from the SENIORS trial (2007) (3)
Endothelium dependent and independent responses in coronary artery disease measured at angioplasty. (1993) (3)
COMET: a proposed mechanism of action to explain the results and concerns about dose (2003) (3)
Death or repair of the myocyte in chronic heart failure * * Editorials published in the Journal of t (2002) (3)
1030-11 Ventricular Myocytes in Culture Express Endothelin-1 (ET-1) mRNA but not ET-2 mRNA or ET-3 mRNA in Response to the Hypertrophic Agonists Phenylephrine and ET-1 (1995) (3)
Comparison of amrinone and pirbuterol in chronic heart failure: Additive effect of isosorbide dinitpate (1982) (3)
Abstract 2005: Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and Non-anemic Patients with Symptomatic Chronic Heart Failure and Iron Deficiency: A Randomised, Controlled, Observer-blinded Trial (FERRIC-HF) (2006) (3)
ARE CALCIUM ANTAGONISTS SAFE ? AUTHOR'S REPLY (1995) (2)
Heart failure in the community and in hospitals : selection and survival of patients in different settings (2003) (2)
Millennium Development Goals: an unbalanced approach to global health (2007) (2)
An annual, prospective, international study of outpatients with cardiovascular disease or risk factors: design and methods of the CardioMonitor registry. (2007) (2)
Mechanism of Cell Death in Myocardial Ischaemia (1983) (2)
Introducing an integrated nursing research programme. (1996) (2)
Differences between Acute and Long Term Metabolic and Endocrine Responses to Oral β-AD-Renergic Agonist Therapy in Chronic Heart Failure (1983) (2)
The DREAM trial (2006) (2)
Potassium exchange and the positive inotropic effect of ouabain in rabbit and human myocardium [proceedings]. (1978) (2)
Diseases of the cardiovascular system (2007) (2)
Skeletal Muscle Potassium Loss During Isometric Exercise (1985) (2)
Haemodynamic and metabolic consequences of angina and myocardial infarction (1987) (2)
Treating Chagas' cardiomyopathy patients with chronic heart failure (2007) (2)
Potassium therapy when treating heart failure with thiazide or loop diuretics. (1985) (2)
Ion Movements Early in Myocardial Ischaemia: Relation to Arrhythmias, Early Contractile Failure and Tissue Necrosis (1992) (2)
1012-121 Lack of heart rate effects on the mortality benefits of carvedilol compared to metoprolol in the patients with heart failure: Results from the carvedilol or metoprolol European trial (COMET) (2004) (2)
Angina--pathological mechanisms, clinical expression and treatment. (1983) (2)
Panel discussion I: Evaluation and management of chronic heart failure (1993) (2)
Ouabain-induced contractures in mammalian heart muscle [proceedings]. (1978) (2)
[Prevention of coronary disease in clinical practice: summary for clinicians]. (1996) (2)
Beta-blockers, myocardial ischaemia and collateral circulation. (2004) (2)
Preparation of cardiac sarcolemma free from endothelial contamination (1984) (2)
1001-26 Exchange of beta-blocking therapy in heart failure patients. Experiences from the post study phase of COMET (the carvedilol or metoprolol European trial) (2004) (2)
Innovative treatments for myocardial infarction; design, purpose and consequences of early studies. (2002) (2)
R Wave Amplitude on the Electrocardiogram: Change with Left Ventricular Volume (1980) (2)
Advances in Myocardiology (1985) (2)
Recovery of severely ischemic myocardium — a challenge for the clinical cardiologist (1990) (2)
The effect of metabolic acidosis and alkalosis on the response to inhaled CO 2 ; a comparison of the rebreathing and steady-state methods of CO 2 administration. (1972) (2)
Calcium channels in the heart. (1991) (2)
Small doses of subcutaneous heparin and postoperative deep venous thrombosis. (1972) (2)
Cellular mechanisms in heart failure (1990) (2)
Introduction 24-Hour Protection and Control: A New Era of Calcium Antagonists (1991) (2)
Treatment of Chronic Stable Angina – Clinical Consequences of Recent Trials (2005) (2)
Corrigendum to: ‘Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy’ [Eur Heart J 2006;27:562–568] (2006) (2)
The WASH study (warfarin/aspirin study in heart failure) rationale, design and end-points (1999) (2)
A new factor in urolithiasis: long-term effects of severe respiratory poliomyelitis. (1973) (2)
Lack of negative inotropic effect on heart muscle following infusion of nicardipine into patients with coronary artery disease. Effects of atrial pacing (1986) (2)
[Prevention of coronary disease in clinical practice. Guidelines of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension]. (1996) (2)
Professor Pavel Lukl 1905–1995 (1997) (1)
The effect of acidosis and manganese on calcium exchange in the myocardium of the rabbit [proceedings]. (1977) (1)
The Role of Changes in Skeletal Muscle Strength and Histochemistry on Exercise Limitation in Severe Heart Failure (1986) (1)
Inhibition of nitric oxide synthase reverses the depressed contraction of cardiac myocytes isolated from endotoxin treated guinea-pigs (1992) (1)
925-41 Coronary Sinus pH During Dipyridamole Infusion in Patients with Angina and Hypertrophic Cardiomyopathy (1995) (1)
Response of cardiac ventricular muscle to an extracellular acidosis (1979) (1)
Diuretics for heart failure. (2006) (1)
The kinetics of efflux of 5,5-dimethyl-2,4-oxazolidinedione (DMO) from the myocardium. (1976) (1)
Abstract 2387: Sex Differences in the Relationship between Echocardiographic Parameters and Clinical Outcomes in Chronic Stable Angina: Data from the ACTION trial (2008) (1)
[Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension]. (1996) (1)
Symptom relief does not reflect reduced clinical events in heart failure: a report from the ATLAS study (1999) (1)
Assessment of Dynamic Cardiac Reserve for the Prediction of the Ventricular Response to Vasodilator Therapy in Heart Failure (1985) (1)
Changing ideas in the treatment of heart failure--an overview. (1987) (1)
HYPOKALÆMIA, DIGITALIS, AND ARRHYTHMIAS (1975) (1)
European role in global cardiology (2000) (1)
Are guidelines achievable today and in the future? Proceedings of a Satellite Symposium held at the 71st European Atherosclerosis Society Congress, Athens, Greece, 28 May 1999. (2000) (1)
Consistent survival benefit of carvedilol over metoprolol irrespective of baseline characteristics of heart failure patients – mode of death evaluation in COMET (2004) (1)
Arrhythmia-Diagnosis and Management. Erik Sandoe and Bjarne Sigurd. Switzerland: Fachmed AG.520. pp. 520. Price: 225 Swiss Francs. (1986) (1)
835-1 A comparison of adverse events occurring with carvedilol or metoprolol in the treatment of heart failure: Results from COMET (2004) (1)
Potassium exchange in the human heart: effect of heart rate and myocardial ischemia. (1990) (1)
ACE inhibitors after myocardial infarction (1994) (1)
Role of potassium in the genesis of arrythmias during ischaemia. Evidence from angioplasty (1986) (1)
Salbutamol intreatment ofheart failure (1980) (1)
THE CARDIAC INSUFFICIENCY BISOPROLOL STUDY II. AUTHORS' REPLY (1999) (1)
A catheter tip pH electrode for use in man [proceedings]. (1979) (1)
Intravenous Iron Sucrose in Anemic and Non-anemic Iron Deficient Patients with CHF: A Randomized, Controlled, Observer-blinded Intervention Study (FERRIC-HF) (2006) (1)
Laser assisted coronary angioplasty. (1988) (1)
Beta-Adrenoceptors in Heart Failure: A Mechanism or a cAMP Follower? (1991) (1)
Effects of prolonged infusion of calcitonin gene-related peptide on the hemodynamics, hormones and renal blood flow in congestive heart failure (1991) (1)
Respiratory oscillations of pulmonary venous and arterial pH in dogs [proceedings]. (1979) (1)
Is inotropic stimulation outdated (1981) (1)
Low frequency oscillations in pulmonary arterial pressure in chronic heart failure. (1993) (1)
Electromechanical effects of pH in guinea-pig cardiac ventricular muscle [proceedings]. (1979) (1)
Mitral stenosis in systemic lupus erythematosus. Successful management by mitral valve replacement. (1988) (1)
Renal excretion of bicarbonate and hydrogen ions: effects of mannitol diuresis in normal man. (1972) (1)
901-96 Long Term Evolution of Left Ventricular Function in Patients with Syndrome X (1995) (1)
Imaging in Acute Myocardial Infarction The Pathologic Basis of Q-Wave and Non-Q-Wave Myocardial Infarction A Cardiovascular Magnetic Resonance Study (2004) (1)
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. (2005) (1)
Myocardial Ischemia and Lipid Metabolism. R. Ferrari, A. M. Karz, A. Shug, O. Visioli. New York and London: Plenum Press, pp. 341. Price: $49.50. (1986) (1)
Should beta-blocker therapy be reduced or withdrawn in patients with worsening heart failure? insights from COMET (2004) (1)
Are calcium antagonists safe? (1995) (1)
The failing heart: Editors: N.S. Dhalla, R.E. Beamish, N. Takeda, M. Nagano Lippincott-Raven Publishers, Philadelphia, New York; 556pp.; stg£76.00; ISBN 0-7817-0311-5 (1996) (1)
Inhibition of calcium uptake by acidosis in the myocardium of the rabbit [proceedings]. (1978) (1)
Left ventricular dysfunction among elderly patients in general practice. Evidence based medicine is not yet possible in these patients. (1999) (1)
Reduced response to camp analogues in myocytes from noradrenaline-treated guinea-pig and failing human heart; Reversal by pertussis toxin (1992) (1)
The DEFIANT study of left ventricular function and exercise performance after acute myocardial infarction (1994) (1)
Proceedings: The effect of an acute acidosis on the potassium content of cardiac muscle. (1973) (1)
Continuous measurement of 47Ca2+ uptake during and after hypoxia in rabbit myocardium. (1980) (1)
β Adrenoceptor blockade in congestive heart failure: future perspectives (1998) (1)
Importance of atrial fibrillation in chronic heart failure in patients treated with β-blockers. results from COMET (2004) (1)
Loss of hydrogen and potassium ions after short periods of myocardial ischaemia in man (1990) (1)
Extracellular Potassium Accumulation during Ischaemia in the Rabbit Heart; Lack of a Correlation with Contractile Failure (1983) (1)
Verapamil in angina pectoris. (1985) (1)
A mechanism for the early loss of potassium from the hypoxic or ischaemic myocardium (1986) (1)
Effects of Acidosis and Weak Acids on the Normal, Hypoxic, and Ischaemic Myocardium (1980) (1)
End stage heart failure options for medical treatment and beyond (2000) (1)
[Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, The European Atherosclerosis Society and the European Hypertension Society. A short overview for general practitioners]. (1996) (1)
Lower patient's cholesterol now. Trial evidence shows clear benefits from secondary prevention. 1995. (2004) (1)
Management of heart failure in the community (2002) (1)
Panel discussion II: Directions for future research (1993) (0)
[Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension]. (1995) (0)
P-231: Effect of long-acting nifedipine on blood pressure control and clinical outcome in patients with stable angina: The action study (2005) (0)
Images in cardiovascular medicine. Magnetic resonance phase velocity mapping in dissecting aortic aneurysm. Demonstration of a proximal intimal tear. (1995) (0)
University of Groningen Tolerability and dose-related effects of nebivolol in elderly patients with heart failure (2017) (0)
Hospital Career Structure (1968) (0)
Calcium and the generation of reperfusion injury (1988) (0)
Angiosarcoma of the heart. (1977) (0)
Issues concerning the use of angiotensin-converting enzyme inhibitors in the treatment of heart failure and myocardial infarction. (1994) (0)
[A possible mechanism for potassium loss in myocardial hypoxia]. (1986) (0)
Subject Index, Vol. 75, 1988 (1988) (0)
OCUS ISSUE: CARDIAC IMAGING ardiovascular Magnetic Resonance, ibrosis, and Prognosis in Dilated Cardiomyopathy (2006) (0)
YI-807 ENHANCED SYSTEMIC NO BIOAVAILABILITY BY GROWTH-HORMONE MEDIATED IGF-1 INCREASE IMPROVES NUMBER AND FUNCTION OF ENDOTHELIAL PROGENITOR CELLS IN AGED INDIVIDUALS (2007) (0)
Neuroendocrine responsetostanding andmild exercise inpatients withuntreated severe congestive heart failure andchronic constrictive pericardit'is (1996) (0)
Chronic Heart Failure in the Rabbit Induced by Longterm Administration of Adriamycin (1986) (0)
Rate Related Changes of Myocardial Balance Potassium in Man (1984) (0)
A Commentary on Clinical Trials in Chronic Heart Failure (2006) (0)
Differential effects of SERCA2a transfection on ventricular arrhythmia susceptibility in the normal rat heart (2007) (0)
Drug Treatment of Heart Failure (2012) (0)
Letter to the editor (1999) (0)
Book Review Congestive Heart Failure Third edition. Edited by Jeffrey D. Hosenpud and Barry H. Greenberg. 869 pp., illustrated. Philadelphia, Lippincott Williams & Wilkins, 2007. $169. 978-0-7817-6285-4 (2007) (0)
Time Limited Exercise Testing on a Self Powered Treadmill (1989) (0)
Small Interference RNA-Mediated Knockdown of eNOS in EPC (2007) (0)
Understanding the jargon: A glossary of terms used (and misused) in the study of ischaemia and reperfusion: Comments (1993) (0)
R waveamplitude during exercise Relation toleft ventricular function andcoronary (1980) (0)
Interpretation of haemodynamic measurements. (1978) (0)
Management and treatment of angina pectoris: new evidence and new ideas with a focus on the results of the ACTION trial (2007) (0)
Calcium and Reperfusion Damage in Heart Muscle (1989) (0)
Book reviewThe Heart: Physiology, Metabolism, Pharmacology Therapy, Lionel H. Opie, Grune & Stratton, London and Orlando (1984), p. 391, Price: £35.00 (1986) (0)
DEMONSTRATIONS (2005) (0)
Effect of drugs on the central haemodynamics and regional blood flow in experimental chronic heart failure (1986) (0)
The role of nicardipine in the treatment of angina pectoris — chairman's comments (1986) (0)
End-Diastolic Coronary Resistance after Reperfusion of the Ischaemic Rabbit Heart; Influence of Nifedipine (1983) (0)
Diurnal variation ofpulmonary arterypressure in chronic heart failure (1989) (0)
Direct measurement ofskeletal muscle fatigue in patients withchronic heart failure (1991) (0)
Pathogenesis ofoedemainchronic severe anaemia: studies ofbodywater andsodium, renal function, haemodynamic variables, andplasma hormones (1993) (0)
DIGOXIN IN HEART FAILURE (1989) (0)
Heterogeneous SERCA2a transfection reduces ventricular arrhythmias in the rat model of heart failure (2008) (0)
Relation between serumuric acidandlower limb bloodflowinpatients withchronic heart failure (1997) (0)
Failure to demonstrate Cl−-HCO3− exchange under control conditions or in response to acidosis in rabbit ventricular muscle * (1985) (0)
Prediction of Maximal Exercise Capacity in Patients with Heart Failure using a Submaximal Exercise Test (1985) (0)
Factors determining symptomsinheart failure: comparison offast andslowexercise tests (1986) (0)
Inability of Superoxide Dismutase and Catalase to Inhibit Calcium Influx on Reoxygenation of Rabbit Myocardium (1987) (0)
Correlation between contractile response to isoprenaline in human left ventricular myocytes and indicators of heart failure (1990) (0)
T02-P-017 Effect of long-acting nifedipine onmortality and cardiovascular morbidity in patients with stable angina requiring treatment: The action trial (2005) (0)
814-3 Effect of Estradiol-17β upon Coronary Arterial Reactivity to Acetylcholine in Men with Coronary Artery Disease (1995) (0)
introducing diuretics . neuroendocrine effects of Untreated heart failure : clinical and (2005) (0)
An individualized prediction of heart failure survival – derivation from PRAISE1 and validation in ELITE2 (2004) (0)
Mechanical response of rabbit myocardium and coronary arteries to leukotriene D4. Failure to demonstrate a role in the pathophysiology of hypoxia. (1985) (0)
Potassium exchange inthehumanheart during atrial pacing andmyocardial ischaemia (1986) (0)
Prognostic impact of symptoms in chronic heart failure - results from COMET (2004) (0)
The Future Role of Inotropic Drugs (2012) (0)
Book Review Cardiology Edited by Michael H. Crawford and John P. DiMarco, with 14 others. 1614 pp., illustrated. New York, Mosby, 2001. $139. 0-7234-3138-8 (2001) (0)
Function of Cardiac Myocytes in Ischemicheart Disease: Comparative Changes in Right and Left Ventricular Cells (1998) (0)
Hemoglobin independently predicts exercise capacity in anemic patients with chronic heart failure (2003) (0)
Letters to the Editor (1976) (0)
Endothelial control oflower limbbloodflowin chronic heart failure (1996) (0)
Myocardial tissue pH in respiratory acidosis and ischaemia*1 (1979) (0)
plasma hormones . renal function , haemodynamic variables , and anaemia : studies of body water and sodium , Pathogenesis of oedema in chronic severe (0)
Medium-term echocardiographic assessment of heart failure patients implanted with an axial flow LVAD (2007) (0)
Impact on mortality of plasma NT-proBNP in chronic heart failure in patients treated with beta-blockers. results from COMET (2004) (0)
Evidence for an Intrinsic Defect of Skeletal Muscle Metabolism in Patients with Chronic Heart Failure (1987) (0)
continuom pulmonary artery pressure (2016) (0)
Inpharzam medical forum--'heart failure today'. (1988) (0)
Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: the ACTION experience. (2010) (0)
PCV27 ECONOMIC EVALUATION OF NEBIVOLOL COMPARED WITH PLACEBO IN ELDERLY PATIENTS WITH HEART FAILURE -A MODEL BASED ANALYSIS ALONGSIDE THE SENIORS TRIAL (2007) (0)
The effect of diuretics on potassium exchange in isolated myocardium (1977) (0)
European (jß Volume 12 Supplement D Pages 1-205 Pericardioscopy—a New Diagnostic Tool in Inflammatory Diseases of the Pericardium the Role of Pericardiectomy in Pericardial Disorders the Value of Endomyocardial Biopsies in Myocarditis and Dilated Cardiomyopathy Endomyocardial Biopsy Findings in Case (0)
Endothelium-independent relaxation of rabbit coronary artery smooth muscles by progesterone (1992) (0)
Book Review: Genetic Epidemiology of Coronary Heart Disease: Past, Present and Future (1985) (0)
Interstitial pH and Contractile Function in Ischaemic Rabbit Myocardium (1979) (0)
Subject Index, Vol. 74, 1987 (1987) (0)
Treatment of Angina – New Attitudes and Emerging Changes in Management (2007) (0)
Effects of endothelin-1 on contractile responses and phosphatidylinositol hydrolysis in isolated myocytes from guinea-pig and rat heart (1992) (0)
Angiosarcoma ofpericardium Problems indiagnosis andmanagement (1976) (0)
Mononitrates: 1st International Symposium, London, June 1986 (1987) (0)
Predictors of Clinical Outcomes in Elderly Patients With Chronic Heart Failure: Results From the SENIORS Sstudy (2009) (0)
Pathophysiology: Discussion II (1993) (0)
Role of calcium ions in hypoxia (1984) (0)
Ventricular long axis function in restrictive disease: Comparison between cardiac amyloidosis and idiopathic restrictive cardiomyopathy (2003) (0)
chronic heart failure . Endothelial control of lower limb blood flow in (2003) (0)
Significant Differences Between Side-Mounted and End-Mounted Intracoronary Doppler Flow Probes for the Measurement of Blood Flow Velocity (1995) (0)
Response to Acidosis in the Myocardium of the Rabbit: Absence of HCO3−-C1− Exchange (1985) (0)
Perspectives in Cardiovascular Research. Volume 10. Arnold M. Katz (Ed.). Clinical Pharmacology of Antiarrhythmic Therapy. Benedict R. Lucchesi, James V. Dingell, Richard P. Schwarz Jr (Eds). New York: Raven Press, pp. 275. Price: £50.00. (1986) (0)
pain and normal coronary arteries . Coronary flow reserve in patients with chest (0)
Calcium Uptake by the Myocardium on Reoxygenation: Relationship between Calcium Uptake and Recovery of Mechanical Function (1987) (0)
Chronic heart failure: early and prophylactic treatment. (1990) (0)
An Economic Analysis of Medication Cost/Life Year Saved in the COMET Trial (2006) (0)
New onset heart failure in the community: One- and three-year mortality and risk factors for 90-day mortality (2003) (0)
PATHOGENESIS OF EDEMA IN CONSTRICTIVE PERICARDITIS. AUTHOR'S REPLIES (1992) (0)
491 Ventricular dyssynchrony as measured by total isovolumic time may predispose to central sleep apnea in chronic heart failure (2005) (0)
[Isolated cardiac myocytes: preparation and use in experimental cardiology]. (1991) (0)
Ca++-cycling in hypertrophied cardiac myocytes (1992) (0)
Enzyme Inhibitors and Calcium Anta onists afier Acute Myoeardia Infarction f (1995) (0)
Alteration in calcium fluxes during the development of myocardial cell damage (1986) (0)
Different Relaxing Effectiveness of Sodium Nitroprusside, Acetylcholine and Substance P on Prostaglandin F2α - and Potassium-Induced Contraction in Isolated Rabbit Coronary Arteries (1991) (0)
Coronary sinus potassium and pH during percutaneous transluminal angioplasty: Temporal relation to contractility and action potential duration (1985) (0)
BrHeartJ 1981 ; 46 : 2245 R wave amplitude during exercise (0)
The prevalence, aetiology and management of heart failure. (1996) (0)
328 Patients' adherence to and perception of medication in a randomised trial, experiences from COMET (2005) (0)
PCV24 THE MAHLER STUDY: DIFFERENCES IN RESOURCE USE FOR THE MANAGEMENT OF CHRONIC HEART FAILURE ACROSS 6 EUROPEAN COUNTRIES (2003) (0)
Prognostic significance and the evolution of renal insufficiency in COMET trial (2004) (0)
Lemakalim attenuates action potential duration (APD) and intracellular Ca2+ ([Ca2+]i) in guinea-pig and human ventricular myocytes (1992) (0)
Potassium Loss from the Rabbit Myocardium during Hypoxia: Evidence for Passive Efflux Linked to Anion Extrusion (1988) (0)
Madrid Declaration and will raise issues that are important in the prevention of cardiovascular disease as addressed in the European Heart Health Charter. References (2007) (0)
Abstract 2564: Hepcidin and TNF{alpha}-Mediated Dysregulation of Monocyte Iron Transport Proteins as the Molecular Basis of Defective Iron Homeostasis in Chronic Heart Failure (2006) (0)
HEART FAILURE Deﬁcient Insulin-Like Growth Factor I in Chronic Heart Failure Predicts Altered Body Composition, Anabolic Deﬁciency, Cytokine and Neurohormonal Activation (2016) (0)
Rheumatology: New Medicine Series, vol 1 (1984) (0)
Effect of Bicycle Exercise on Plasma Potassium in Man (1988) (0)
433 Reverse remodelling with nebivolol in elderly heart failure patients with or without left ventricular systolic dysfunction. Results of the SENIORS echocardiographic substudy (2005) (0)
Message from the President of the European Society of Cardiology (1995) (0)
The Use of Maximal Oxygen Uptake Capacity to Assess Left Ventricular Function in Severe Aortic Regurgitation (1986) (0)
Failure to demonstrate sodium efflux in association with calcium influx on reoxygenation of the hypoxic rabbit myocardium (1986) (0)
Faculty Opinions recommendation of Optimal medical therapy with or without PCI for stable coronary disease. (2007) (0)
Comparison of losartan and captopril in ELITE II (2000) (0)
Medium-term echocardiographic assessment of heart failure patients with an axial flow LVAD (2005) (0)
Clinical Investigations Regional Differences in the Characteristics and Treatment of Patients Participating in an International Heart Failure Trial (1998) (0)
Abstract 5327: Opposing Influences Of Serca2a Gene Transfer Upon Catecholamine-induced Ventricular Arrhythmias In Normal And Failing Hearts (2008) (0)
ATP-Sensitive Potassium Channels and Myocardial Ischemia (1998) (0)
Inhibition by barium and glibenclamide of the net loss of 86Rb from isolated rabbit myocardium during hypoxia (1990) (0)
Dose response curve of ouabain and inhibition of the potassium pump in human and rabbit myocardium (1977) (0)
Neurogenic and endothelial modulation of hypoxia-induced relaxation of rabbit coronary artery smooth muscles (1992) (0)
Calcium fluxes in hypoxic and ischaemic myocardium (1981) (0)
Myocardial Cell Abnormalities in Heart Failure: Experience from Studies on Single Myocytes (1995) (0)
Endothelium-dependent relaxation is impaired in aortic rings from a rat model of heart failure (1991) (0)
932-83 Contribution of Gi-protein Effects to β-Adrenoceptor Desensitisation in Single Ventricular Myocytes from Aged Guinea-pig Heart (1995) (0)
The influence of right heart catheterisation on pulmonary pressure in chronic heart failure: relationship to neuroendocrinal changes arterial (1991) (0)
Prevalence of Anaemia and the Effects of Nebivolol on Hemoglobin Values in Patients with Chronic Heart Failure (2009) (0)
Computer Analysis of 12 Lead Treadmill Exercise Tests (1982) (0)
Effects of carvedilol versus metoprolol on hemostasis and fibrinolysis in patients with chronic heart failure (2004) (0)
THROMBOLYTIC THERAPY (1989) (0)
343 Depression in men with chronic heart failure: prevalence and hormone determinants (2007) (0)
Wednesday, 29 August 2012 (2012) (0)
A method for haemodynamic assessment in conscious rabbits; use after acute pulmonary embolisation (1985) (0)
Patients who have dilated cardiomyopathy must have a trial of bridge to recovery: the case against that proposition. (2007) (0)
Surface morphology and calcium control in myocytes from a rat MI model of heart failure (2008) (0)
Congenital heart disease Hyponatraemia : a strong predictor of mortality in adults with congenital heart disease (2010) (0)
324 Sleep disordered breathing in congestive heart failure: prevalence and characteristics (2004) (0)
Determinants of Coronary Resistance on Reperfusion after Global Ischaemia in the Isolated Rabbit Heart (1982) (0)
ECHOCARDIOGRAPHIC SCREENING FOR RHEUMATIC HEART DISEASE AMONG 6,270 ASYMPTOMATIC SCHOOL CHILDREN IN INDIA: THE RHEUMATIC (RHEUMATIC HEART ECHO UTILIZATION AND MONITORING ACTUARIAL TRENDS IN INDIAN CHILDREN) STUDY (2011) (0)
Comparison of inhibitory G-protein effects in human, guinea-pig and rat isolated ventricular myocytes (1990) (0)
Salbutamol incardiogenic shock complicating acute myocardial infarction (1980) (0)
CARDIOPLEGIA (1981) (0)
Abstract 2904: Deficiency in Circulating Testosterone Predicts Reduction in Exercise Capacity in Men in the Course of Chronic Heart Failure (2007) (0)
WHF2-1 Diastolic Heart Failure; A Medical Creation or Management Problem (2009) (0)
Heart Failure: Treatment with β -Adrenoceptor Antagonists (1998) (0)
NICE: guessing is not guidance. National Institute for Clinical Excellence. (2002) (0)
Suppression of Erythroid Cell Development in Patients with Chronic Heart Failure and Anemia of Unknown Origin: Evidence of an Immune Basis (2009) (0)
The Effect of Acute Changes in CO2 on the Mechanical Properties of Papillary Muscles from Chronically Hypercapnic Rats (1977) (0)
Poster session III * Friday 10 December 2010, 08:30-12:30 (2010) (0)
Haemodynamics, Distribution of Blood Flow and Lactate Concentrations at Rest and during Treadmill Exercise in Chronic Heart Failure: Effects of Oral Pirbuterol (1982) (0)
Degradation and altered function of the calcium-release channel during acute ischaemia: A possible mechanism of myocardial stunning (1990) (0)
Nitrates in the Treatment of Heart Failure -Concluding Remarks (1987) (0)
Inhomogenous Kinetic Distribution of DMO in the Myocardium (1976) (0)
The Negative Inotropic Effect of CO2 and its Relation to Ionic Exchange (1975) (0)
Qt dispersion is not associated with left ventricular function in elderly patients with symptomatic heart failure: ELITE II substudy (2002) (0)
Bone loss in cardiac cachectic CHF patients (1996) (0)
Transmembrane ion fluxes (1986) (0)
Continuous Measurement of Tissue and Coronary Venous pH during Myocardial Ischaemia in Dogs (1979) (0)
A selection of abstracts to be presented at the XVIIth Congress of the European Society of Cardiology, August 20–24,1995, Amsterdam, The Netherlands (1995) (0)
impaired ventricular function . assessment of patients with Respiratory gas exchange in the (0)
Treatment of Heart Failure by “Afterload” Reduction: Vasodilator or Angiotensin Converting Enzyme Inhibitor? (1990) (0)
syndrome X . coronary artery disease or with atrial pacing in patients with sinus oxygen saturation during Continuous recording of coronary (2005) (0)
Routine exercise testing in angina pectoris. (1979) (0)
HEMODYNAMIC EFFECTS OF AN IONIC AND A NEW NONIONIC CONTRAST AGENT: RELATIONSHIP TO CHANGES IN CORONARY SINUS IONIZED CALCIUM (1982) (0)
Peroxide induced calcium uptake in cardiac muscle-some common characteristicswith reoxygenation induced calcium uptake* (1984) (0)
Pathophysiologic Mechanisms to Outcome iu Heart Failure (2016) (0)
Some issues concerning treatment in patients after myocardial infarction. (1995) (0)
Deficiency: FERRIC-HF: A Randomized, Controlled, Observer-Blinded Trial Nonanemic Patients With Symptomatic Chronic Heart Failure and Iron Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and (2011) (0)
Intracellular pH and tension during acidosis in beating ventricular muscle from theguinea pig (1984) (0)
Cardiac metabolism: Editors: A.J. Drake-Holland and M.I.M. Noble John Wiley & Sons Ltd, London, 1983; 562 pp.; £39.50 (1984) (0)
The human cardiac sarcoplasmic reticulum calcium-release channel (1990) (0)
in Seniors With Heart Failure) (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization and Preserved Left Ventricular Ejection Fraction: Data From SENIORS Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired (2011) (0)
Improving diastolic function after myocardial infarction : proceedings of a satellite symposium held during the XVIIth Congress of the European Society of Cardiology, August 1995 (1996) (0)
Atheroma to heart failure : a continuum of disease? (1991) (0)
Remodelling of the heart is not a proven clinical concept (2004) (0)
myocardial ischaemia . heart during atrial pacing and Potassium exchange in the human (0)
Proceedings: Glycoside inotropy and K+ efflux in presence of an acidosis. (1976) (0)
New Insights into Beta Blocker Therapy in Heart Failure (2005) (0)
Iconographies supplémentaires de l'article : Variation in severity and type of sleep-disordered breathing throughout 4 nights in patients with heart failure (2011) (0)
Proceedings: Dissociation of the inotropic effect of acetylstrophanthidin in myocardium and the increase of K+ efflux. (1975) (0)
infarction . complicating acute myocardial Salbutamol in cardiogenic shock (0)
Newsletter from the Society (1996) (0)
Calcium Fluxes during and after Hypoxia in Rabbit Myocardium (1978) (0)
Continuous Recording of Arterial and Coronary Sinus pH during Pacing-Induced Ischaemia (1980) (0)
Th-W52:5 Age-dependent impairment of endothelial progenitor cells is corrected by growth hormone mediated increase of insulin-like growth factor-1 (2006) (0)
Factors Affecting the Acute Response, Increase in Exercise Performance and Survival in Patients Receiving Vasodilator Therapy for Chronic Heart Failure (1984) (0)
Aldosterone in syndromes of untreated congestive heart failure (1996) (0)
THROMBOLYTIC THERAPY (1989) (0)
Effects of Ischaemia and Reperfusion on Mechanical Function, Extracellular Space and Calcium Exchange in Isolated Rabbit Myocardium (1980) (0)
249 Immune-mediated dysregulation of cellular iron transport proteins as the molecular basis of defective iron homeostasis in chronic heart failure (2007) (0)
Perforation thresholds andsafety factors ininvivo coronarylaser angioplasty (1988) (0)
Objective Assessment of Exercise Capacity in Patients with Heart Failure - A non-Invasive Determination (1985) (0)
THE EFFECTS OF STANDARD AND NEW CONTRAST AGENTS ON CARDIAC HEMODYNAMICS AND CORONARY SINUS IONIZED CALCIUM (1984) (0)
Syndrome X: A Non-Ischaemic Syndrome? — “False Positive” ST-Segment Shifts, Ischaemia, Myocardial Perfusion Abnormalities And Increased Sensitivity To Pain In Syndrome X (1994) (0)
Whole blood calcium activity during cardiopulmonary bypass (2005) (0)
Superoxide dismutase and catalase do not directly inhibit the uptake of calcium on reoxygenation after a period of hypoxia in the rabbit myocardium (1986) (0)
Incidence of diagnosis of heart failure made by general practitioners and survival rate of the patients: Data from 696884 persons in the UK (2000) (0)
Does cell size affect the rest decay of contractility in guinea-pig myocytes?☆ (1992) (0)
Panel Discusdon II : Directions for Future Research (2016) (0)
Letter: Hypokalaemia, digitalis, and arrhythmias. (1975) (0)
Evidence against a Direct Effect of Potassium-Sparing Diuretics on the Myocardium (1978) (0)
Abstract 21453: Disordered Iron Homeostasis in Chronic Heart Failure and its Relation to Anemia, Exercise Capacity and Survival (2010) (0)
Coronary sinus pHduring percutaneoustransluminal coronaryangioplasty: early development ofacidosis during myocardial ischaemia inman (1987) (0)
Commentary on "Effects of ischaemia and reperfusion on calcium exchange and mechanical function in isolated rabbit myocardium". (2000) (0)
Myocardial perfusion inhumans: Whatcan we measure? (1993) (0)
Sad news this year for Nat. Rev. Cardiol. (2009) (0)
Abnormal cation fluxes in the myocardium early during ischaemia (1992) (0)
Reduction of infarct size: a misleading concept? (1983) (0)
Cardiac failure. (1997) (0)

This paper list is powered by the following services:

Philip Alexander Poole‐wilson's Academic­Influence.com Rankings

Why Is Philip Alexander Poole‐wilson Influential?

Philip Alexander Poole‐wilson's Published Works

Published Works

Philip Alexander Poole‐wilson's AcademicInfluence.com Rankings